Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Lucid Diagnostics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q3 2022
- Shares held
- 1.92M
- −388.3K (−16.9%) vs. Q3 2022
- Total value
- $2.60M
- −$919.0K (−26.1%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 4
- 9 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUCD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $65.7M |
| Q1 2026 | 103 | $41.0M |
| Q4 2025 | 89 | $35.1M |
| Q3 2025 | 86 | $35.6M |
| Q2 2025 | 72 | $21.9M |
| Q1 2025 | 49 | $14.1M |
| Q4 2024 | 33 | $2.80M |
| Q3 2024 | 29 | $2.00M |
| Q2 2024 | 34 | $1.74M |
| Q1 2024 | 30 | $1.69M |
| Q4 2023 | 25 | $2.67M |
| Q3 2023 | 24 | $2.24M |
| Q2 2023 | 18 | $2.59M |
| Q1 2023 | 19 | $2.49M |
| Q4 2022 | 23 | $2.60M |
| Q3 2022 | 23 | $3.58M |
| Q2 2022 | 31 | $5.55M |
| Q1 2022 | 32 | $9.09M |
| Q4 2021 | 35 | $17.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Lucid Diagnostics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Luminus Management LLC | 825,000 | $1.12M | 0.28% | −21,662−2.6% | Reduced |
| Vanguard Group Inc | 319,433 | $434.4K | 0.00% | +670.0% | Added |
| Nantahala Capital Management, LLC | 279,537 | $380.2K | 0.03% | −6,895−2.4% | Reduced |
| Bridgeway Capital Management, LLC | 135,000 | $183.6K | 0.00% | −50,000−27.0% | Reduced |
| Kornitzer Capital Management Inc | 133,000 | $180.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 41,543 | $56.0K | 0.00% | +2,427+6.2% | Added |
| Levin Capital Strategies, L.P. | 36,799 | $50.0K | 0.01% | +36,799 | New |
| Verition Fund Management LLC | 36,166 | $49.2K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 33,850 | $46.0K | 0.00% | −7,000−17.1% | Reduced |
| BlackRock Inc. | 18,238 | $24.8K | 0.00% | +412+2.3% | Added |
| Millennium Management LLC | 17,814 | $24.0K | 0.00% | −6,602−27.0% | Reduced |
| LPL Financial LLC | 14,400 | $19.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 10,521 | $14.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,565 | $4.85K | 0.00% | −1,396−28.1% | Reduced |
| Arcus Capital Partners, LLC | 3,100 | $4.22K | 0.00% | +3,100 | New |
| Tower Research Capital LLC (TRC) | 2,561 | $3.00K | 0.00% | −4,721−64.8% | Reduced |
| CWM, LLC | 1,920 | $3.00K | 0.00% | −100−5.0% | Reduced |
| Belpointe Asset Management LLC | 1,500 | $2.04K | 0.00% | +1,500 | New |
| Morgan Stanley | 893 | $1.21K | 0.00% | −18,361−95.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,000 | $1.00K | 0.00% | +678+210.6% | Added |
| Wells Fargo & Company | 58 | $79 | 0.00% | +2+3.6% | Added |
| Bank of America Corp | 18 | $24 | 0.00% | +18 | New |
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −264,653−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,333−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,602−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −973−100.0% | Sold out |